CN107480456A - clinical trial management method and system - Google Patents
clinical trial management method and system Download PDFInfo
- Publication number
- CN107480456A CN107480456A CN201710724386.4A CN201710724386A CN107480456A CN 107480456 A CN107480456 A CN 107480456A CN 201710724386 A CN201710724386 A CN 201710724386A CN 107480456 A CN107480456 A CN 107480456A
- Authority
- CN
- China
- Prior art keywords
- information
- test
- clinical trial
- clinical
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000007726 management method Methods 0.000 title claims abstract description 68
- 238000012360 testing method Methods 0.000 claims abstract description 145
- 238000011160 research Methods 0.000 claims abstract description 105
- 239000003814 drug Substances 0.000 claims abstract description 69
- 229940079593 drug Drugs 0.000 claims abstract description 67
- 238000012545 processing Methods 0.000 claims description 13
- 238000004891 communication Methods 0.000 claims description 8
- 238000002474 experimental method Methods 0.000 claims 2
- 238000012552 review Methods 0.000 abstract description 46
- 238000000034 method Methods 0.000 abstract description 21
- 230000000144 pharmacologic effect Effects 0.000 abstract description 6
- 230000000739 chaotic effect Effects 0.000 abstract 1
- 230000008569 process Effects 0.000 description 16
- 229940000406 drug candidate Drugs 0.000 description 12
- 239000003777 experimental drug Substances 0.000 description 12
- 238000012216 screening Methods 0.000 description 9
- 238000010276 construction Methods 0.000 description 7
- 238000013461 design Methods 0.000 description 6
- 230000007115 recruitment Effects 0.000 description 6
- 230000006399 behavior Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 238000007689 inspection Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000019580 granularity Nutrition 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000000819 phase cycle Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Medical Treatment And Welfare Office Work (AREA)
Abstract
本发明公开了一种临床试验管理方法和系统,其中,方法包括:获取试验药物信息,根据预设药物信息对试验药物信息进行审核,根据审核结果建立试验项目;根据试验项目构建试验方案;试验方案包括研究内容信息和研究阶段信息;根据试验方案采集受试者信息,将受试者信息录入试验方案中;根据受试者信息按照研究阶段信息进行研究内容信息的相关临床试验,得到对应的临床试验数据,并记录进试验方案,完成临床试验管理。本发明通过试验方案对受试者进行集中管理,并记录相关数据,使得用药方和监管部门核查方便,研究者随时同步实时数据,实现了对临床试验的多样化、一体化管理,减少了临床试验数据混乱的现象,增强临床药理试验结果的可靠性。
The invention discloses a clinical trial management method and system, wherein, the method includes: obtaining test drug information, reviewing the test drug information according to the preset drug information, establishing test items according to the review results; constructing a test plan according to the test items; The protocol includes research content information and research stage information; collect subject information according to the test plan, and enter the subject information into the test plan; conduct relevant clinical trials based on the subject information and research stage information to obtain the corresponding Clinical trial data, and recorded into the trial protocol, complete clinical trial management. The present invention centrally manages the subjects through the test plan and records relevant data, which makes it convenient for the prescription and the supervision department to check, and the researcher can synchronize the real-time data at any time, realizing the diversified and integrated management of the clinical trial, reducing the need for clinical trials. The phenomenon of chaotic test data enhances the reliability of clinical pharmacological test results.
Description
技术领域technical field
本发明涉及信息管理技术领域,尤其涉及一种临床试验管理方法和系统。The invention relates to the technical field of information management, in particular to a clinical trial management method and system.
背景技术Background technique
临床试验是一个复杂的试验体系,涉及到病理学、药理学、伦理学、统计学等多方面的内容。按照国家食品药品监督管理局颁布的《药物临床试验质量管理规范》中临床试验的定义,临床试验是指任何在人体(病人或健康志愿者)进行药物的系统性研究,以证实或揭示试验药物的作用、不良反应及/或试验药物的吸收、分布、代谢和排泄,目的是确定试验药物的疗效与安全性。在国外,把参加临床试验的人员称作志愿者,国内一般称为“受试者”,志愿者里面有健康的人,也有病人,这主要看是参加什么样的试验。我们平时接触最多的试验,还是由病人参加的,目的在于考察新药有没有疗效,有没有副作用的试验。大型三甲医院每年都承担着几百项的试验项目,受制药公司的委托为药物的上市作不同期的临床试验研究,需招募大批的受试者来进行受试者并观察药物的反应。Clinical trials are a complex experimental system involving many aspects such as pathology, pharmacology, ethics, and statistics. According to the definition of clinical trials in the "Quality Management Practices for Drug Clinical Trials" promulgated by the State Food and Drug Administration, clinical trials refer to any systematic research on drugs in humans (patients or healthy volunteers) to confirm or reveal the experimental drugs. The effect, adverse reactions and/or absorption, distribution, metabolism and excretion of the test drug, the purpose is to determine the efficacy and safety of the test drug. In foreign countries, people who participate in clinical trials are called volunteers, and in China they are generally called "subjects". Volunteers include healthy people and patients, which mainly depends on what kind of trial they are participating in. The trials that we have the most contact with usually involve patients. The purpose is to investigate whether new drugs have curative effects and whether they have side effects. Large tertiary hospitals undertake hundreds of experimental projects every year. They are entrusted by pharmaceutical companies to conduct clinical trial research for different periods of drug marketing. They need to recruit a large number of subjects to conduct subjects and observe drug responses.
目前几乎所有医院对于受试者的管理都还依靠目前医院临床上已经在使用的一些已有系统,例如门诊诊间系统、住院医嘱系统等,使得受试者的管理和普通病人一样,完成基本的需求;由于不同系统间数据相对孤立,很容易造成数据记录不完整、数据传输滞后、数据设计随意性大、数据统计分析不专业、受试者管理不规范等诸多问题,导致制药方、用药方和监管部门核查困难,研究者无法同步实时数据,数据混乱等现象,影响了临床药理试验结果的可靠性。At present, almost all hospitals still rely on some existing systems that have been used clinically in the hospital for the management of subjects, such as the outpatient clinic system, inpatient doctor order system, etc., so that the management of subjects is the same as that of ordinary patients. Due to the relative isolation of data between different systems, it is easy to cause many problems such as incomplete data records, lagging data transmission, random data design, unprofessional data statistical analysis, and non-standard management of subjects, resulting in many problems such as pharmaceutical prescriptions, drug use, etc. It is difficult for parties and regulatory authorities to verify, researchers cannot synchronize real-time data, and data confusion affects the reliability of clinical pharmacological test results.
发明内容Contents of the invention
本发明的目的是提供一种临床试验管理方法和系统,本发明通过试验方案对受试者进行集中管理,并记录相关数据,使得用药方和监管部门核查方便,研究者随时同步实时数据,实现了对临床试验的多样化、一体化管理,减少了临床试验数据混乱的现象,增强临床药理试验结果的可靠性。The purpose of the present invention is to provide a clinical trial management method and system. The present invention centrally manages the subjects through the test plan and records relevant data, so that the prescriptions and regulatory authorities can be easily checked, and researchers can synchronize real-time data at any time to achieve It improves the diversified and integrated management of clinical trials, reduces the confusion of clinical trial data, and enhances the reliability of clinical pharmacological test results.
本发明提供了一种临床试验管理方法,包括以下步骤:The invention provides a clinical trial management method, comprising the following steps:
获取试验药物信息,根据预设药物信息对所述试验药物信息进行审核,根据审核结果建立试验项目;Obtain the information of the experimental drug, review the information of the experimental drug according to the preset drug information, and establish the experimental project according to the review result;
根据所述试验项目构建试验方案;所述试验方案包括研究内容信息和研究阶段信息;Construct a test plan according to the test project; the test plan includes research content information and research phase information;
根据所述试验方案采集受试者信息,将所述受试者信息录入所述试验方案中;Collect subject information according to the test plan, and enter the subject information into the test plan;
根据所述受试者信息按照所述研究阶段信息进行所述研究内容信息的相关临床试验,得到对应的临床试验数据,并记录进所述试验方案,完成临床试验管理。According to the subject information and the research stage information, the relevant clinical trial of the research content information is carried out to obtain the corresponding clinical trial data, and record it into the trial plan to complete the clinical trial management.
作为一种可实施方式,所述根据所述试验项目构建试验方案,包括以下步骤:As an implementable manner, said constructing a test scheme according to said test project includes the following steps:
将所述试验项目进行划分,得到研究阶段信息;Divide the test items to obtain research phase information;
将所述试验项目按照研究阶段信息进行处理,得到研究内容信息;Process the test items according to the research stage information to obtain research content information;
根据所述研究阶段信息和所述研究内容信息进行二维关系组合,并通过通讯协议与医务内部系统进行对接,生成试验方案。Combining the two-dimensional relationship according to the research stage information and the research content information, and connecting with the medical internal system through a communication protocol to generate a test plan.
作为一种可实施方式,所述根据所述试验项目构建试验方案,还包括以下步骤:As an implementable manner, said constructing a test scheme according to said test project also includes the following steps:
在将所述试验项目进行划分之前,根据预设的研究人员信息和与其对应的权限对所述试验项目设置试验类型,得到试验类型信息。Before dividing the test items, the test type is set for the test items according to the preset researcher information and the corresponding authority, and the test type information is obtained.
作为一种可实施方式,所述根据所述试验项目构建试验方案,还包括以下步骤:As an implementable manner, said constructing a test scheme according to said test project also includes the following steps:
在得到研究内容信息之后,对所述研究内容信息进行分类,得到分类内容信息。After the research content information is obtained, the research content information is classified to obtain classified content information.
作为一种可实施方式,本发明提供的临床试验管理方法还包括以下步骤:As an implementable mode, the clinical trial management method provided by the present invention also includes the following steps:
在根据所述受试者信息按照所述研究阶段信息进行所述研究内容信息的相关临床试验之后,得到费用数据,根据所述费用数据进行记账处理,并生成多维财务报表。After the relevant clinical trial of the research content information is carried out according to the subject information and the research stage information, the expense data is obtained, the accounting process is performed according to the expense data, and a multi-dimensional financial statement is generated.
相应的,本发明还提供一种临床试验管理系统,包括试验药物获取模块、试验方案构建模块、受试者录入模块以及临床试验管理模块;Correspondingly, the present invention also provides a clinical trial management system, including a trial drug acquisition module, a trial protocol construction module, a subject entry module, and a clinical trial management module;
所述试验药物获取模块,用于获取试验药物信息,根据预设药物信息对所述试验药物信息进行审核,根据审核结果建立试验项目;The test drug acquisition module is used to obtain test drug information, review the test drug information according to the preset drug information, and establish test items according to the review results;
所述试验方案构建模块,用于根据所述试验项目构建试验方案;所述试验方案包括研究内容信息和研究阶段信息;The test plan building module is used to construct a test plan according to the test project; the test plan includes research content information and research phase information;
所述受试者录入模块,用于根据所述试验方案采集受试者信息,将所述受试者信息录入所述试验方案中;The subject input module is used to collect subject information according to the test plan, and enter the subject information into the test plan;
所述临床试验管理模块,用于根据所述受试者信息按照所述研究阶段信息进行所述研究内容信息的相关临床试验,得到对应的临床试验数据,并记录进所述试验方案,完成临床试验管理。The clinical trial management module is used to conduct clinical trials related to the research content information according to the subject information according to the research stage information, obtain corresponding clinical trial data, and record them into the trial plan to complete the clinical trials. Trial management.
作为一种可实施方式,所述试验方案构建模块包括划分单元、处理单元以及组合单元;As an implementable manner, the test plan building module includes a division unit, a processing unit and a combination unit;
所述划分单元,用于将所述试验项目进行划分,得到研究阶段信息;The division unit is used to divide the test items to obtain research phase information;
所述处理单元,用于将所述试验项目按照研究阶段信息进行处理,得到研究内容信息;The processing unit is configured to process the test items according to the research stage information to obtain research content information;
所述组合单元,用于根据所述研究阶段信息和所述研究内容信息进行二维关系组合,并通过通讯协议与医务内部系统进行对接,生成试验方案。The combination unit is used to combine the two-dimensional relationship according to the research stage information and the research content information, and connect with the medical internal system through a communication protocol to generate a test plan.
作为一种可实施方式,所述试验方案构建模块,还包括设置单元;As an implementable manner, the construction module of the test scheme also includes a setting unit;
所述设置单元,用于在将所述试验项目进行划分之前,根据预设的研究人员信息和与其对应的权限对所述试验项目设置试验类型,得到试验类型信息。The setting unit is configured to set the test type for the test item according to the preset researcher information and the corresponding authority before dividing the test item, and obtain the test type information.
作为一种可实施方式,所述试验方案构建模块,还包括分类单元;As an implementable manner, the test protocol building block also includes a classification unit;
所述分类单元,用于在得到研究内容信息之后,对所述研究内容信息进行分类,得到分类内容信息。The classification unit is configured to classify the research content information after obtaining the research content information to obtain classified content information.
作为一种可实施方式,所述临床试验管理模块还包括财务报表单元;As an implementable manner, the clinical trial management module also includes a financial statement unit;
所述财务报表单元,用于在根据所述受试者信息按照所述研究阶段信息进行所述研究内容信息的相关临床试验之后,得到费用数据,根据所述费用数据进行记账处理,并生成多维财务报表。The financial statement unit is used to obtain expense data after conducting relevant clinical trials of the research content information according to the subject information and the research stage information, perform accounting processing according to the expense data, and generate Multidimensional financial statements.
与现有技术相比,本技术试验方案具有以下优点:Compared with the prior art, the technical test scheme has the following advantages:
本发明提供的临床试验管理方法和系统,首先根据预设药物信息对试验药物信息进行审核,根据审核结果建立试验项目,再根据试验项目构建试验方案;通过构建的试验方案完成招募受试者,并根据试验方案的研究阶段信息进行研究内容信息的相关临床试验完成对受试者的临床试验管理。通过试验方案对受试者进行集中管理,并记录相关数据,使得用药方和监管部门核查方便,研究者随时同步实时数据,实现了对临床试验的多样化、一体化管理,减少了临床试验数据混乱的现象,增强临床药理试验结果的可靠性。In the clinical trial management method and system provided by the present invention, firstly, the trial drug information is reviewed according to the preset drug information, the test items are established according to the review results, and the test program is constructed according to the test items; the recruitment of subjects is completed through the constructed test program, According to the research stage information of the trial protocol, the relevant clinical trials of the research content information are carried out to complete the clinical trial management of the subjects. The subjects are managed centrally through the test plan, and relevant data are recorded, which makes it easy for the prescription and the regulatory department to check. The researchers synchronize real-time data at any time, realizing the diversified and integrated management of clinical trials, and reducing clinical trial data. The phenomenon of confusion enhances the reliability of clinical pharmacological test results.
附图说明Description of drawings
图1为本发明实施例一提供的临床试验管理方法的流程示意图;FIG. 1 is a schematic flow diagram of a clinical trial management method provided in Embodiment 1 of the present invention;
图2为图1中建立试验项目的流程示意图;Fig. 2 is the schematic flow chart of setting up test project in Fig. 1;
图3为本发明实施例二提供的临床试验管理系统的结构示意图。FIG. 3 is a schematic structural diagram of a clinical trial management system provided in Embodiment 2 of the present invention.
图中:100、试验药物获取模块;200、试验方案构建模块;210、设置单元;220、划分单元;230、处理单元;240、分类单元;250、组合单元;300、受试者录入模块;400、临床试验管理模块;410、财务报表单元。In the figure: 100, test drug acquisition module; 200, test protocol building module; 210, setting unit; 220, division unit; 230, processing unit; 240, classification unit; 250, combination unit; 300, subject entry module; 400. Clinical trial management module; 410. Financial statement unit.
具体实施方式detailed description
以下结合附图,对本发明上述的和另外的技术特征和优点进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明的部分实施例,而不是全部实施例。The above and other technical features and advantages of the present invention will be clearly and completely described below in conjunction with the accompanying drawings. Apparently, the described embodiments are only some of the embodiments of the present invention, not all of them.
请参阅图1,本发明实施例一提供的临床试验管理方法,包括以下步骤:Please refer to Figure 1, the clinical trial management method provided by Embodiment 1 of the present invention includes the following steps:
S100、获取试验药物信息,根据预设药物信息对试验药物信息进行审核,根据审核结果建立试验项目;S100. Acquire the information of the experimental drug, review the information of the experimental drug according to the preset drug information, and establish a test item according to the review result;
S200、根据试验项目构建试验方案;试验方案包括研究内容信息和研究阶段信息;S200. Construct a test plan according to the test project; the test plan includes research content information and research stage information;
S300、根据试验方案采集受试者信息,将受试者信息录入试验方案中;S300. Collect subject information according to the test plan, and enter the subject information into the test plan;
S400、根据受试者信息按照研究阶段信息进行研究内容信息的相关临床试验,得到对应的临床试验数据,并记录进试验方案,完成临床试验管理。S400 , according to the subject information and the research stage information, conduct the relevant clinical trial of the research content information, obtain the corresponding clinical trial data, and record it into the trial plan, and complete the clinical trial management.
需要说明的是,在签署相关项目合同后,试验药物入库试验药物中心药房完成试验药物信息的获取,可以是通过人工直接输入和/或扫描输入的方式。再将试验药物信息录入药房数据库,得到试验药物数据库;从而将试验药物与正常药物分开,避免试验药物信息的数据混乱。预设药物信息就是每个试验药物的标准信息,通过将预设药物信息与试验药物信息进行对比、判断、筛选等方式进行审核,在审核通过之后建立建立试验项目。而需要审核的试验药物信息不仅包括试验药物的基本信息、批次信息、有效期信息以及编号信息。还包括每次对试验药物进行操作后产生的数据,比如库存信息、出入库信息,摆药操作、药物处方的审方、科室回收药物的审核、厂商的药物回收等。It should be noted that after signing the relevant project contract, the pharmacy of the trial drug center will complete the acquisition of the trial drug information, which can be directly input manually and/or scanned. Then enter the experimental drug information into the pharmacy database to obtain the experimental drug database; thereby separating the experimental drug from the normal drug and avoiding the data confusion of the experimental drug information. The preset drug information is the standard information of each test drug, which is reviewed by comparing, judging, and screening the preset drug information with the test drug information, and establishing the test project after the review is passed. The trial drug information that needs to be reviewed includes not only the basic information of the trial drug, batch information, expiration date information, and serial number information. It also includes the data generated after each operation of the experimental drug, such as inventory information, storage information, drug filling operation, drug prescription review, department review of drug recall, manufacturer's drug recall, etc.
如图2所示,建立试验项目的具体过程包括项目申请、伦理审查、合同签立、药物库建立以及启动会召开。As shown in Figure 2, the specific process of establishing a trial project includes project application, ethics review, contract signing, drug library establishment, and kick-off meeting.
S110、项目申请包括项目填报与审核,项目填报,院内人员账号是通过试验项目与医院OA系统对接将人事信息导入直接生成的,而院外人员则需通过在试验项目内注册账号,然后进行审核后生成;并且需要为不用的用户账号分配相应的权限,可通过分配不同的角色来定义相应用户的权限(角色可分为申办方、研究者、项目负责人、科主任、机构办公室秘书、机构办公室主任等);申办方登录试验项目后进行项目的在线填报,并上传项目资料,确认提交后将会进入审核阶段,审核阶段可分为负责人审核、科主任审核、机构办公室审核,不同角色的用户进入系统后在‘我的待办’中可看到当前的待办任务(基于任务驱动的流程化管理),审核过程中可进行项目资料的在线批阅并提取批阅信息作为项目驳回的理由,机构审核通过后项目将生成唯一的受理号,大大减少项目审核的工作量;通过项目的在线填报将成功创建全院的试验项目库,项目相关的信息及项目资料数据都可以进行关联搜索和查看,并且不同角色用户拥有项目的不同操作权限和不同范围的项目查看权限(我填报项目、我负责项目、某专业组项目、全院项目等)。S110. Project application includes project reporting and review, project reporting, the account number of the personnel in the hospital is directly generated by importing the personnel information through the connection between the pilot project and the hospital OA system, and the personnel outside the hospital need to register an account in the pilot project, and then after the review Generated; and it is necessary to assign corresponding permissions to unused user accounts, which can be defined by assigning different roles (roles can be divided into sponsor, researcher, project leader, department director, institutional office secretary, institutional office director, etc.); the sponsor will fill in the project online after logging in to the trial project, and upload the project information. After confirming the submission, it will enter the review stage. The review stage can be divided into person-in-charge review, department director review, and institution office review. After entering the system, the user can see the current to-do tasks in "My To-Do" (based on task-driven process management). During the review process, the online review of project materials can be carried out and the review information can be extracted as the reason for project rejection. After the institutional review is passed, the project will generate a unique acceptance number, which greatly reduces the workload of project review; through the online reporting of the project, a test project database of the whole hospital will be successfully created, and project-related information and project data can be searched and viewed in association , and users with different roles have different operation permissions and project viewing permissions in different scopes (I fill in the project, I am in charge of the project, a professional group project, the whole hospital project, etc.).
S120、伦理审查为项目申请机构审核通过后才进入的阶段,伦理审查包括初始审查、修正案审查、持续审查、不良事件的检测和评估等类型,不同的审查类型需要填写不一样的申请内容但拥有相同的流程管理;项目负责人在线进行伦理审查申请,填写申请内容和上传伦理资料,确认并提交后,伦理秘书进行项目的形式审查,形式审查通过后为每个项目分配两位主审进行审查,主审审查过程中对项目内容和项目资料进行审查,并提交审查结果,伦理上会后,可在系统内进行伦理会议到会委员的在线签到、在线查看项目递交的伦理资料、伦理秘书在线填写会议纪要、对伦理审查结果在线投票等,系统可自动根据投票结果将项目驳回或者通过,伦理审查通过后的项目可在线生成伦理批件。S120. Ethical review is a stage that enters after the project applicant has passed the review. Ethical review includes initial review, amendment review, continuous review, detection and evaluation of adverse events, etc. Different review types need to fill in different application content but Have the same process management; the project leader applies for ethics review online, fills in the application content and uploads ethics materials, and after confirmation and submission, the ethics secretary conducts the formal review of the project. After the formal review is passed, two chief reviewers are assigned to each project. Review, review the project content and project materials during the review process, and submit the review results. After the ethics meeting, you can perform online sign-in of the ethics meeting members in the system, check the ethics materials submitted by the project online, and the ethics secretary Online filling of meeting minutes, online voting on ethical review results, etc., the system can automatically reject or pass the project according to the voting results, and the ethical approval document can be generated online for projects that pass the ethical review.
S130、合同管理是在伦理审核通过并且成功获取伦理批件后才进入的阶段,项目合同签署成功后,需即时将合同的重要信息(如合同内规定的费用信息等)录入系统,并将合同扫描件传入系统供后期参阅,合同录入完成后将为每个项目生产唯一的合同号,后续流程的进行中合同号将作为该项目的唯一标识。S130. Contract management is a stage that enters after the ethics review is passed and the ethics approval document is successfully obtained. After the project contract is successfully signed, it is necessary to immediately enter the important information of the contract (such as the cost information specified in the contract, etc.) into the system, and scan the contract After the contract entry is completed, a unique contract number will be produced for each project, and the contract number will be used as the unique identifier of the project during the subsequent process.
S140、药物库建立是在合同管理通过并且成功后才进入的阶段,根据预设药物信息对试验药物信息进行审核并入库,再根据试验药物信息建立药物库。S140. Establishing the drug library is a stage entered after the contract management is passed and successful. The trial drug information is reviewed and stored according to the preset drug information, and then the drug library is established according to the trial drug information.
启动会召开是在合同管理通过并且成功后才进入的阶段,该阶段可以进行也可以直接跳过。The kick-off meeting is a stage entered after the contract management is passed and successful. This stage can be carried out or skipped directly.
试验方案是严格参照对应的试验项目构建的,试验方案是定义了每个受试者在相应的研究阶段信息(具有一定时间范围的研究阶段周期)需要进行相应的研究内容信息和评估信息的数据表。评估信息包括在临床试验数据中。临床试验都是按照周期性的阶段进行,不同的试验药物的试验周期一般是不同的;所以将试验项目进行划分,得到研究阶段信息。这里的研究阶段信息可以是筛选期、试验周期、治疗中止、随访等;并按要求规定阶段的开始时间和结束时间。而研究内容信息就是在对应的研究阶段需要进行的研究内容,可以是知情同意、入选、体格检查、合并用药、肿瘤评估、给药、生命体征、不良事件等。于其他实施例中,还可以将试验方案内容、eCRF(受试者电子病例报告)等信息加入试验方案中。The test plan is constructed strictly with reference to the corresponding test items. The test plan defines the data that each subject needs to conduct corresponding research content information and evaluation information in the corresponding research phase information (research phase cycle with a certain time range). surface. Evaluation information is included in the clinical trial data. Clinical trials are carried out in periodic stages, and the trial cycles of different experimental drugs are generally different; therefore, the trial items are divided to obtain the research stage information. The research stage information here can be the screening period, trial cycle, treatment suspension, follow-up, etc.; and specify the start time and end time of the stage as required. The research content information is the research content that needs to be carried out in the corresponding research phase, which can be informed consent, enrollment, physical examination, combined medication, tumor assessment, drug administration, vital signs, adverse events, etc. In other embodiments, information such as the content of the trial protocol and eCRF (electronic case report of subjects) can also be added to the trial protocol.
对于受试者信息的采集需要说明的是,首先是根据试验方案对招募的受试者信息进行筛选,筛选出符合试验方案的受试者信息,并按照招募的时间顺序将受试者信息录入,也可直接通过受试者在本院的就诊卡号/病历号通过通讯协议从已有的医院内部系统中完成受试者信息筛选录入;比如,在受试者招募页面,筛选号根据规则自动生成,选择受试者类型(门诊/住院),输入卡号/病历号搜索将通过WebService或者HttpClient的方式直接从HIS中获取数据,大大减少信息输入的时间;确认信息无误后点击“保存”按钮,将根据规则作判断,比如三个月内是否有参加过其他的试验、是否门诊病人冒充住院病人、是否在住院病人参与其他门诊的试验等;新增成功后受试者将会出现在左侧菜单,不同的颜色表示受试者状态(正常试验、筛选未通过、剔除等)。What needs to be explained about the collection of subject information is that firstly, the recruited subject information is screened according to the test plan, and the subject information conforming to the test plan is screened out, and the subject information is entered in the chronological order of recruitment. , you can also directly complete the screening and entry of subject information from the existing internal system of the hospital through the communication protocol through the patient's card number/medical record number in the hospital; for example, on the subject recruitment page, the screening number is automatically entered according to the rules. Generate, select the subject type (outpatient/inpatient), enter the card number/medical record number to search, and the data will be directly obtained from HIS through WebService or HttpClient, greatly reducing the time for information input; after confirming that the information is correct, click the "Save" button, Judgments will be made according to the rules, such as whether they have participated in other trials within three months, whether outpatients pretend to be inpatients, whether inpatients participate in other outpatient trials, etc. After successful addition, subjects will appear on the left Menu, different colors indicate the status of the subject (normal test, screening failed, excluded, etc.).
本发明提供的临床试验管理方法,首先根据预设药物信息对试验药物信息进行审核,根据审核结果建立试验项目,再根据试验项目构建试验方案;通过构建的试验方案完成招募受试者,并根据试验方案的研究阶段信息进行研究内容信息的相关临床试验完成对受试者的临床试验管理。通过试验方案对受试者进行集中管理,并记录相关数据,使得用药方和监管部门核查方便,研究者随时同步实时数据,实现了对临床试验的多样化、一体化管理,减少了临床试验数据混乱的现象,增强临床药理试验结果的可靠性。In the clinical trial management method provided by the present invention, first, the trial drug information is reviewed according to the preset drug information, the test items are established according to the review results, and the test program is constructed according to the test items; the recruitment of subjects is completed through the constructed test program, and according to The research stage information of the trial protocol carries out the relevant clinical trial of the research content information and completes the clinical trial management of the subjects. The subjects are managed centrally through the test plan, and relevant data are recorded, which makes it easy for the prescription and the regulatory department to check. The researchers synchronize real-time data at any time, realizing the diversified and integrated management of clinical trials, and reducing clinical trial data. The phenomenon of confusion enhances the reliability of clinical pharmacological test results.
进一步的,步骤S200包括以下步骤:Further, step S200 includes the following steps:
S210、将试验项目进行划分,得到研究阶段信息;S210. Divide the test items to obtain research phase information;
S220、将试验项目按照研究阶段信息进行处理,得到研究内容信息;S220. Process the experimental items according to the research stage information to obtain research content information;
S230、根据研究阶段信息和研究内容信息进行二维关系组合,并通过通讯协议与医务内部系统进行对接,生成试验方案。S230. Combining two-dimensional relationships according to the research stage information and research content information, and connecting with the medical internal system through a communication protocol to generate a test plan.
试验方案的设计:基于模块化、可配置的设计思路,后面的受试者的行为都建立在试验方案上,试验方案可以分解为一个二维关系来看待,y为研究内容,x为研究阶段,两者之间形成二维关系。临床试验都是按照周期性的阶段进行,不同的试验药物的试验周期一般是不同的;所以将试验项目进行划分,得到研究阶段信息。研究阶段信息设定各阶段的时间范围,并且根据阶段对应的时间范围对受试者的整个试验提前作出时间预期提示(给药时间等)、预警等;研究内容信息就是在每个研究阶段对应具体的临床行为有化验、医技检查、开药、知情同意、入组筛查、eCRF等。按照试验方案来进行临床试验管理将大大减少后期本受试者招募后的操作成本(试验方案与受试者是1:n的关系),并且也将受试者的临床行为严格框定在试验方案的设计之上,对临床试验的质控提供依据;按照各个试验方案规定的病历报告样式进行eCRF(受试者电子病历报告),用于后期受试者相关的病历填入。在试验方案中根据研究内容信息也可以设定一些规则;比如,筛选号规则(定义筛选号的位数和组合内容,用于受试者筛选时自动生成相应的筛选号)、入排标准(试验方案上规定的入选和排除标准,主要受试者不符合其中任何一项入选规则或者符合任何一项排除标准,该受试者都将筛选失败)、pk采血/采尿的时间点规则(设计连续采样的时间点,比如+0h、+0.5h、+1h、+1.25h、+1.5h、+2.0h等,该时间点是表示以给药时间作为参考的,在给药时间前后多少时间内采样,则系统根据时间点规则再参考给药时间自动计算理论的采血时间)等的规则。试验方案从垂直维度实现受试者的所有行为的集中管理(将单个项目的所有受试者的临床行为集中管理,非常直观的反应该项目的所有受试者情况),从水平维度实现临床试验的一体化管理(从单个受试者的知情同意后入组直至受试者成功完成该试验的整个过程管理)。The design of the test plan: Based on the modular and configurable design idea, the behavior of the following subjects is based on the test plan. The test plan can be decomposed into a two-dimensional relationship, y is the research content, and x is the research stage , forming a two-dimensional relationship between them. Clinical trials are carried out in periodic stages, and the trial cycles of different experimental drugs are generally different; therefore, the trial items are divided to obtain the research stage information. The research stage information sets the time range of each stage, and according to the corresponding time range of the stage, the time expectation reminder (drug administration time, etc.), early warning, etc. are given to the subjects in the whole test in advance; the research content information is the corresponding Specific clinical behaviors include laboratory tests, medical technical examinations, drug prescribing, informed consent, enrollment screening, eCRF, etc. Clinical trial management in accordance with the trial protocol will greatly reduce the operating cost of the later recruitment of the subject (the relationship between the trial protocol and the subject is 1:n), and also strictly frame the clinical behavior of the subject in the trial protocol Based on the design of the clinical trial, it provides a basis for the quality control of the clinical trial; the eCRF (subject electronic medical record report) is performed according to the medical record report format specified in each trial protocol, and is used for filling in the medical records related to the subjects in the later stage. In the test plan, some rules can also be set according to the research content information; for example, the screening number rule (defining the number of digits and combination content of the screening number, which is used to automatically generate the corresponding screening number when the subject is screened), the inclusion and exclusion criteria ( The inclusion and exclusion criteria stipulated in the trial protocol, if the main subject does not meet any of the inclusion rules or meets any of the exclusion criteria, the subject will fail to screen), the time point rules for pk blood collection/urine collection ( Design time points for continuous sampling, such as +0h, +0.5h, +1h, +1.25h, +1.5h, +2.0h, etc. Time sampling, the system automatically calculates the theoretical blood sampling time) and other rules according to the time point rule and then referring to the administration time. The test plan realizes the centralized management of all the behaviors of the subjects from the vertical dimension (centralized management of the clinical behaviors of all the subjects of a single project, which is very intuitive to reflect the situation of all the subjects of the project), and realizes the clinical trials from the horizontal dimension Integrated management (from the enrollment of a single subject after the informed consent to the successful completion of the subject's entire process management of the trial).
根据研究阶段信息和研究内容信息进行二维关系组合,并通过通讯协议与医务内部系统进行对接;比如通过WebService或者HttpClient的方式直接从HIS中获取已有的受试者信息数据;或者从LIS、PACS中获取待使用的数据;与医院系统HIS、LIS、PACS等无缝对接,使得相对独立但不孤立(医院系统中仍然会有该有的数据),将不同粒度的数据都关联在一起,研究的数据就很难全面的表现出来。Combine the two-dimensional relationship according to the research stage information and research content information, and connect with the medical internal system through the communication protocol; for example, directly obtain the existing subject information data from HIS through WebService or HttpClient; or from LIS, Acquire the data to be used in PACS; seamlessly connect with the hospital system HIS, LIS, PACS, etc., making it relatively independent but not isolated (there will still be data in the hospital system), and linking data of different granularities together, It is difficult to present the research data comprehensively.
进一步的,步骤S200还包括以下步骤:Further, step S200 also includes the following steps:
在将试验项目进行划分之前,根据预设的研究人员信息和与其对应的权限对试验项目设置试验类型,得到试验类型信息。Before dividing the test items, the test type is set for the test items according to the preset researcher information and the corresponding authority, and the test type information is obtained.
需要说明的是,根据试验项目设置对应的试验方案的试验类型信息,根据预设的研究人员信息和与其对应的权限对试验项目进行试验类型的设置;试验类型信息包括开放、单盲以及双盲三种;用于区分试验的类型直接影响后期试验处方的开立方式;预设的研究人员包括研究者、研究护士、药物管理、CRC等,不同的研究人员对应不同的权限。如果是开放的,则在医生开处方的时直接确认试验药物的编号(特性信息),实现处方信息的采集;如果是单盲/双盲的,在医生开立处方时不对试验药物的编号进行选择,在研究护士到试验药房取药时,再进行试验药物的编号的输入,实现处方信息的采集。后续进行出库处理。It should be noted that, according to the test type information of the test plan corresponding to the test item setting, the test type of the test item is set according to the preset researcher information and the corresponding authority; the test type information includes open, single-blind and double-blind Three types; the type used to distinguish the test directly affects the way of prescribing the late test prescription; the preset researchers include investigators, research nurses, drug management, CRC, etc., and different researchers correspond to different authorities. If it is open, the number (characteristic information) of the test drug will be directly confirmed when the doctor prescribes to realize the collection of prescription information; if it is single-blind/double-blind, the number of the test drug will not be checked when the doctor prescribes. Select, when the research nurse goes to the test pharmacy to pick up the medicine, then input the serial number of the test drug to realize the collection of prescription information. Subsequent outbound processing.
进一步的,步骤S200还包括以下步骤:Further, step S200 also includes the following steps:
在得到研究内容信息之后,对研究内容信息进行分类,得到分类内容信息。After the research content information is obtained, the research content information is classified to obtain the classified content information.
对研究内容信息进行分类,可分为CRF、检验、检查、给药等,分类内容信息的目的是实现受试者对不同研究内容的平台可以设计差异化的执行方式,最后将独立的研究阶段信息和研究内容信息通过二维关系组合起来,实现不同的研究阶段对应相应的研究内容,实现了临床试验的多样化、一体化。Classify the research content information, which can be divided into CRF, inspection, inspection, drug administration, etc. The purpose of classifying content information is to realize that the subjects can design differentiated execution methods for different research content platforms, and finally the independent research stage Information and research content information are combined through a two-dimensional relationship to realize the corresponding research content corresponding to different research stages, and realize the diversification and integration of clinical trials.
进一步的,临床试验管理方法还包括以下步骤:Further, the clinical trial management method also includes the following steps:
在根据受试者信息按照研究阶段信息进行研究内容信息的相关临床试验之后,得到费用数据,根据费用数据进行记账处理,并生成多维财务报表。After conducting relevant clinical trials with research content information based on subject information and research stage information, cost data is obtained, and accounting processing is performed based on cost data, and multidimensional financial statements are generated.
对受试者按照试验方案进行相关临床试验生成多维财务报表举例说明:Examples of multi-dimensional financial statements generated by subjects in accordance with the test protocol for relevant clinical trials:
在受试者管理区域,新受试者所处阶段默认是第一个阶段,并且会显示本阶段的所有的待办任务,任务驱动,完成所有的任务才能进入下一阶段,底部多tab页面动态显示该阶段所对应的研究内容(根据阶段动态变化),由于门诊流程和住院流程的差异,每次点击受试者都会通过WebService或者HttpClient的方式与医院HIS系统内的信息校对受试者类型(是门诊病人还是住院病人),及时进行受试者类型的更改,受试者的类型(门诊/住院)将会影响研究内容的实际执行路径;检验/检查按试验方案中该周期的定义中获取的,批量执行即可,系统自动计费(不需垫付),门诊病人直接到窗口抽血/登记,住院病人按住院流程进行即可,未在试验方案中定义的额外开单可到“额外开单”处开立,需要写明开单原因;在历史检验/检查单中可查看该受试者的所有检验/检查结果,分不同项目周期、不同病人类型(门诊/住院),自动提取异常指标,并提醒研究者上报AE(异常事件);选择开单药物(该项目入库的药物),选择编号(开放试验选择对应编号,单盲/双盲则不选择),开单医生统一核对掉,核对之后会进入药房摆药(期间可作废、取消),相应的人到试验中心药房取药,在历史处方单中可以查看该受试者所有的新药处方,对已发药的可进行退药操作,写明理由(需申办方证明文件方可),药房有确认操作,各科室将药物回收至试验中心药房,药房管理员进行核对;In the subject management area, the stage of a new subject is the first stage by default, and all to-do tasks in this stage will be displayed, task-driven, complete all tasks to enter the next stage, and the multi-tab page at the bottom Dynamically display the research content corresponding to this stage (dynamic changes according to the stage). Due to the difference between the outpatient process and the inpatient process, each click on the subject will check the subject type with the information in the hospital's HIS system through WebService or HttpClient (Outpatient or inpatient), change the subject type in time, the type of subject (outpatient/hospitalization) will affect the actual implementation path of the research content; inspection/inspection is in accordance with the definition of the cycle in the trial protocol Acquired, batch execution is enough, the system automatically bills (no advance payment is required), outpatients go directly to the window to draw blood/registration, inpatients can follow the hospitalization process, and additional bills that are not defined in the trial plan can go to " "Additional billing" is issued, and the reason for billing needs to be stated; all test/check results of the subject can be viewed in the historical test/check list, which is divided into different project cycles and different patient types (outpatient/inpatient), automatically Extract abnormal indicators and remind researchers to report AEs (abnormal events); select the ordering drug (drugs put into storage for this project), select the number (select the corresponding number for open trials, do not select for single-blind/double-blind), and bill the doctor After checking, they will go to the pharmacy to place the medicine (can be invalidated or canceled during the period), and the corresponding person will go to the pharmacy of the test center to pick up the medicine. In the historical prescription list, all the new drug prescriptions of the subject can be viewed. The drug withdrawal operation can be carried out, and the reasons should be stated (the sponsor’s certification documents are required), and the pharmacy has a confirmation operation, and each department will return the drug to the pharmacy of the test center, and the pharmacy administrator will check;
在上述受试者按照试验方案进行相关临床试验时,每一个研究阶段的研究内容完成后都会进行数据统计和报表的输入,临床试验机构管理部门将可实时监控各专业组的各个项目的进度情况,并以多维度展示财务数据,供医院财务部门与厂商进行费用结算。所有的临床试验招募受试者后,受试者由于药物研究需要所进行的化验、医技检查等都是免费进行的,药厂会与医院按照生成的多维财务报表统一结算,成功解决受试者的费用问题,不需要受试者垫付费用再进行报销的繁杂操作,在方便临床试验的同时将保证试验的质量。When the above-mentioned subjects conduct relevant clinical trials according to the trial plan, data statistics and report input will be carried out after the research content of each research stage is completed, and the management department of the clinical trial institution will be able to monitor the progress of each project of each professional group in real time , and display financial data in multiple dimensions for the financial department of the hospital to settle expenses with the manufacturer. After all clinical trials recruit subjects, the test subjects and medical technical examinations required for drug research are all free of charge, and the pharmaceutical company will settle with the hospital in accordance with the generated multi-dimensional financial statements to successfully settle the test cases. There is no need for the complicated operation of the subject to pay the expenses in advance and then reimbursement, which will ensure the quality of the trial while facilitating the clinical trial.
基于同一发明构思,本发明实施例还提供一种临床试验管理系统,该系统的实施可参照上述方法的过程实现,重复之处不再冗述。Based on the same inventive concept, an embodiment of the present invention also provides a clinical trial management system. The implementation of the system can be realized by referring to the process of the above method, and the repetition will not be repeated.
如图3所示,是本发明实施例二提供的临床试验管理系统的结构示意图,包括试验药物获取模块100、试验方案构建模块200、受试者录入模块300以及临床试验管理模块400;As shown in FIG. 3 , it is a schematic structural diagram of the clinical trial management system provided by Embodiment 2 of the present invention, including a trial drug acquisition module 100, a trial protocol construction module 200, a subject entry module 300, and a clinical trial management module 400;
试验药物获取模块100用于获取试验药物信息,根据预设药物信息对试验药物信息进行审核,根据审核结果建立试验项目;The test drug acquisition module 100 is used to acquire test drug information, review the test drug information according to the preset drug information, and establish test items according to the review results;
试验方案构建模块200用于根据试验项目构建试验方案;试验方案包括研究内容信息和研究阶段信息;The test plan construction module 200 is used to construct the test plan according to the test items; the test plan includes research content information and research stage information;
受试者录入模块300用于根据试验方案采集受试者信息,将受试者信息录入试验方案中;The subject input module 300 is used to collect subject information according to the test plan, and enter the subject information into the test plan;
临床试验管理模块400用于根据受试者信息按照研究阶段信息进行研究内容信息的相关临床试验,得到对应的临床试验数据,并记录进试验方案,完成临床试验管理。The clinical trial management module 400 is used to conduct clinical trials related to research content information according to subject information and research stage information, obtain corresponding clinical trial data, and record them into the trial protocol to complete clinical trial management.
进一步的,试验方案构建模块200包括划分单元220、处理单元230以及组合单元250;Further, the test plan construction module 200 includes a division unit 220, a processing unit 230 and a combination unit 250;
划分单元220用于将试验项目进行划分,得到研究阶段信息;The division unit 220 is used to divide the test items to obtain research phase information;
处理单元230用于将试验项目按照研究阶段信息进行处理,得到研究内容信息;The processing unit 230 is used to process the test items according to the research stage information to obtain the research content information;
组合单元250用于根据研究阶段信息和研究内容信息进行二维关系组合,并通过通讯协议与医务内部系统进行对接,生成试验方案。The combination unit 250 is used to combine the two-dimensional relationship according to the research stage information and the research content information, and connect with the medical internal system through a communication protocol to generate a test plan.
进一步的,试验方案构建模块200,还包括设置单元210;Further, the test plan construction module 200 also includes a setting unit 210;
设置单元210用于在将试验项目进行划分之前,根据预设的研究人员信息和与其对应的权限对试验项目设置试验类型,得到试验类型信息;The setting unit 210 is used to set the test type for the test project according to the preset researcher information and the corresponding authority before dividing the test project, and obtain the test type information;
根据试验类型信息分配研究人员和设置对应的权限。Assign researchers and set corresponding permissions according to the test type information.
进一步的,试验方案构建模块200还包括分类单元240;Further, the test plan construction module 200 also includes a classification unit 240;
分类单元240用于在得到研究内容信息之后,对研究内容信息进行分类,得到分类内容信息。The classification unit 240 is configured to classify the research content information after obtaining the research content information to obtain classified content information.
进一步的,临床试验管理模块400还包括财务报表单元410;Further, the clinical trial management module 400 also includes a financial statement unit 410;
财务报表单元410,用于在根据受试者信息按照研究阶段信息进行研究内容信息的相关临床试验之后,得到费用数据,根据费用数据进行记账处理,并生成多维财务报表。The financial statement unit 410 is used to obtain expense data after conducting relevant clinical trials of research content information according to subject information and research stage information, perform accounting processing according to expense data, and generate multidimensional financial statements.
本发明提供的临床试验管理系统,首先根据预设药物信息对试验药物信息进行审核,根据审核结果建立试验项目,再根据试验项目构建试验方案;通过构建的试验方案完成招募受试者,并根据试验方案的研究阶段信息进行研究内容信息的相关临床试验完成对受试者的临床试验管理。通过试验方案对受试者进行集中管理,并记录相关数据,使得用药方和监管部门核查方便,研究者随时同步实时数据,实现了对临床试验的多样化、一体化管理,减少了临床试验数据混乱的现象,增强临床药理试验结果的可靠性。The clinical trial management system provided by the present invention first reviews the trial drug information according to the preset drug information, establishes the test items according to the review results, and then constructs the test program according to the test items; completes the recruitment of subjects through the constructed test program, and The research stage information of the trial protocol carries out the relevant clinical trial of the research content information and completes the clinical trial management of the subjects. The subjects are managed centrally through the test plan, and relevant data are recorded, which makes it easy for the prescription and the regulatory department to check. The researchers synchronize real-time data at any time, realizing the diversified and integrated management of clinical trials, and reducing clinical trial data. The phenomenon of confusion enhances the reliability of clinical pharmacological test results.
本发明虽然已以较佳实施例公开如上,但其并不是用来限定本发明,任何本领域技术人员在不脱离本发明的精神和范围内,都可以利用上述揭示的方法和技术内容对本发明技术试验方案做出可能的变动和修改,因此,凡是未脱离本发明技术试验方案的内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化及修饰,均属于本发明技术试验方案的保护范围。Although the present invention has been disclosed as above with preferred embodiments, it is not intended to limit the present invention, and any person skilled in the art can use the methods disclosed above and technical content to analyze the present invention without departing from the spirit and scope of the present invention. Therefore, any simple modifications, equivalent changes and modifications made to the above embodiments according to the technical essence of the present invention, which do not depart from the content of the technical test plan of the present invention, all belong to the technical aspects of the present invention. Scope of protection of the trial protocol.
Claims (10)
- A kind of 1. clinical trial management method, it is characterised in that comprise the following steps:Trial drug information is obtained, the trial drug information is audited according to default drug information, according to auditing result Establish pilot project;Testing program is built according to the pilot project;The testing program includes research contents information and conceptual phase information;Subject information is gathered according to the testing program, by testing program described in subject information's typing;The relevant clinical that the research contents information is carried out according to the conceptual phase information according to the subject information is tested, Corresponding clinical testing data is obtained, and is recorded into the testing program, completes clinical trial management.
- 2. clinical trial management method as claimed in claim 1, it is characterised in that described built according to the pilot project is tried Proved recipe case, comprises the following steps:The pilot project is divided, obtains conceptual phase information;The pilot project is handled according to conceptual phase information, obtains research contents information;Two-dimentional relation combination is carried out according to the conceptual phase information and the research contents information, and passes through communications protocol and doctor Business built-in system is docked, and generates testing program.
- 3. clinical trial management method as claimed in claim 2, it is characterised in that described built according to the pilot project is tried Proved recipe case, it is further comprising the steps of:Before the pilot project is divided, according to default researcher's information and corresponding authority to described Testing items setting test type, obtain test type information.
- 4. clinical trial management method as claimed in claim 2, it is characterised in that described built according to the pilot project is tried Proved recipe case, it is further comprising the steps of:After research contents information is obtained, the research contents information is classified, obtains classifies content information.
- 5. clinical trial management method as claimed in claim 1, it is characterised in that further comprising the steps of:Tried in the relevant clinical for carrying out the research contents information according to the conceptual phase information according to the subject information After testing, cost data is obtained, book keeping operation processing is carried out according to the cost data, and generate multidimensional financial statement.
- A kind of 6. clinical trial management system, it is characterised in that including trial drug acquisition module, testing program structure module, Subject's recording module and clinical trial management module;The trial drug acquisition module, for obtaining trial drug information, according to default drug information to the trial drug Information is audited, and pilot project is established according to auditing result;The testing program builds module, for building testing program according to the pilot project;The testing program includes grinding Study carefully content information and conceptual phase information;Subject's recording module, for gathering subject information according to the testing program, the subject information is recorded Enter in the testing program;The clinical trial management module, for according to the subject information according to the conceptual phase information carry out described in grind Study carefully the relevant clinical experiment of content information, obtain corresponding clinical testing data, and record into the testing program, complete clinical Trial.
- 7. clinical trial management system as claimed in claim 6, it is characterised in that the testing program structure module includes drawing Subdivision, processing unit and assembled unit;The division unit, for the pilot project to be divided, obtain conceptual phase information;The processing unit, for the pilot project to be handled according to conceptual phase information, obtain research contents information;The assembled unit, for carrying out two-dimentional relation combination according to the conceptual phase information and the research contents information, And docked by communications protocol with medical matters built-in system, generate testing program.
- 8. clinical trial management system as claimed in claim 7, it is characterised in that the testing program builds module, also wraps Include setting unit;The setting unit, for before the pilot project is divided, according to default researcher's information and with Its corresponding authority obtains test type information to the Testing items setting test type.
- 9. clinical trial management system as claimed in claim 7, it is characterised in that the testing program builds module, also wraps Include taxon;The taxon, for after research contents information is obtained, classifying to the research contents information, being divided Class content information.
- 10. clinical trial management system as claimed in claim 6, it is characterised in that the clinical trial management module is also wrapped Include financial statement unit;The financial statement unit, for carrying out the research according to the conceptual phase information according to the subject information After the relevant clinical experiment of content information, cost data is obtained, book keeping operation processing is carried out according to the cost data, and generate more Tie up financial statement.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710724386.4A CN107480456A (en) | 2017-08-22 | 2017-08-22 | clinical trial management method and system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710724386.4A CN107480456A (en) | 2017-08-22 | 2017-08-22 | clinical trial management method and system |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107480456A true CN107480456A (en) | 2017-12-15 |
Family
ID=60602160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710724386.4A Pending CN107480456A (en) | 2017-08-22 | 2017-08-22 | clinical trial management method and system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107480456A (en) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108830034A (en) * | 2018-05-25 | 2018-11-16 | 陈育聪 | A kind of medicine clinical development information processing system and its method |
CN108932968A (en) * | 2018-05-21 | 2018-12-04 | 上海市第六人民医院 | A kind of clinical trial subjects management system |
CN109559236A (en) * | 2018-10-27 | 2019-04-02 | 平安医疗健康管理股份有限公司 | The method and apparatus of drug reimbursement Information abnormity |
CN109616190A (en) * | 2018-12-25 | 2019-04-12 | 天津阿贝斯努科技有限公司 | Center Ethic review management system and management method |
CN109671478A (en) * | 2018-12-24 | 2019-04-23 | 天津阿贝斯努科技有限公司 | Clinical test case report form quality control system and method for quality control |
CN109817290A (en) * | 2018-12-25 | 2019-05-28 | 天津阿贝斯努科技有限公司 | One clinical trial phase management system and management method |
CN109978341A (en) * | 2019-02-28 | 2019-07-05 | 北京新研汇医药研发有限公司 | A kind of monitoring method and apparatus of clinical test |
CN110335649A (en) * | 2019-06-04 | 2019-10-15 | 林东方 | A kind of clinical drug trials data platform based on Filemaker database |
CN111341455A (en) * | 2020-02-10 | 2020-06-26 | 厦门茶蕊生物医药科技有限公司 | Clinical test integrated cloud platform management system, method and storage medium |
CN111599429A (en) * | 2020-05-19 | 2020-08-28 | 苏州筑奇医药科技有限公司 | Out-of-hospital data acquisition method, equipment device and storage medium for clinical testees |
CN111640475A (en) * | 2020-04-29 | 2020-09-08 | 上海米帝信息技术有限公司 | Management system for clinical test |
CN111986743A (en) * | 2020-08-07 | 2020-11-24 | 上海神桥医药科技有限公司 | Medical auditing method and application thereof |
CN112154511A (en) * | 2018-05-23 | 2020-12-29 | 希米科医疗保健机构有限公司 | Subject candidate extraction method and subject candidate extraction system |
CN112164469A (en) * | 2020-10-14 | 2021-01-01 | 杭州卓健信息科技有限公司 | Clinical scientific research data acquisition management system |
CN112185489A (en) * | 2020-10-14 | 2021-01-05 | 上海妙一生物科技有限公司 | Information reminding method, system, equipment and storage medium |
CN112365940A (en) * | 2020-10-16 | 2021-02-12 | 零氪科技(北京)有限公司 | System and method for screening subjects |
CN112655051A (en) * | 2018-05-14 | 2021-04-13 | 美国控股实验室公司 | Method and system for identifying subjects enrolled in a clinical trial |
CN112712862A (en) * | 2019-10-24 | 2021-04-27 | 北京新研汇医药研发有限公司 | Method, device and system for generating clinical research time schedule |
CN113035295A (en) * | 2020-10-29 | 2021-06-25 | 上海米帝信息技术有限公司 | Patient information management system |
CN113053478A (en) * | 2021-03-11 | 2021-06-29 | 上海交通大学医学院附属新华医院 | Project and quality control system suitable for clinical test of medicine |
CN113139727A (en) * | 2021-04-23 | 2021-07-20 | 广东丸美生物技术股份有限公司 | Cosmetic human body efficacy test subject management system and method |
CN113314192A (en) * | 2021-06-17 | 2021-08-27 | 医渡云(北京)技术有限公司 | Clinical trial data processing system, method, device and storage medium |
CN113327656A (en) * | 2021-06-09 | 2021-08-31 | 上海天蟾生物科技有限公司 | Clinical test detection recording method for arenobufagin hard mass softening and liver softening tablets |
CN113707248A (en) * | 2021-08-31 | 2021-11-26 | 郑州大学第一附属医院 | Clinical trial subject examination and inspection process management system, method and computer storage medium |
CN113889205A (en) * | 2021-09-30 | 2022-01-04 | 上海柯林布瑞信息技术有限公司 | A screening method for clinical research patients and a corresponding device |
CN114334072A (en) * | 2021-12-31 | 2022-04-12 | 科临达康医药生物科技(北京)有限公司 | Method, system and equipment for establishing clinical trial development plan database |
CN114334044A (en) * | 2021-12-24 | 2022-04-12 | 浙江太美医疗科技股份有限公司 | Methods, apparatus, electronic devices and media for data presentation, project configuration |
CN114360668A (en) * | 2021-12-24 | 2022-04-15 | 浙江太美医疗科技股份有限公司 | Data processing method, data processing device, data configuration device, computer equipment and storage medium |
CN114388116A (en) * | 2022-01-14 | 2022-04-22 | 北京嘉和海森健康科技有限公司 | Processing method and system of visiting schedule table and electronic equipment |
CN116580798A (en) * | 2023-07-13 | 2023-08-11 | 南京纳实医学科技有限公司 | Research method for dynamic and accurate clinical test selection of subject medicine |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004038560A3 (en) * | 2002-10-23 | 2004-12-09 | Capital Surini Group Internat | Systems and methods for clinical trials information management |
CN105550532A (en) * | 2016-02-19 | 2016-05-04 | 南京迈拓医药科技有限公司 | Management system applied to medical clinical test |
CN106295091A (en) * | 2015-05-13 | 2017-01-04 | 仁智(苏州)医学研究有限公司 | Clinical trial tracking based on cloud storage and system |
-
2017
- 2017-08-22 CN CN201710724386.4A patent/CN107480456A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004038560A3 (en) * | 2002-10-23 | 2004-12-09 | Capital Surini Group Internat | Systems and methods for clinical trials information management |
CN106295091A (en) * | 2015-05-13 | 2017-01-04 | 仁智(苏州)医学研究有限公司 | Clinical trial tracking based on cloud storage and system |
CN105550532A (en) * | 2016-02-19 | 2016-05-04 | 南京迈拓医药科技有限公司 | Management system applied to medical clinical test |
Non-Patent Citations (3)
Title |
---|
周克雄 等: ""药物临床试验综合信息管理系统功能设计"", 《中国药事》 * |
温雯 等: ""基于药物临床试验项目管理系统的临床试验全程管理"", 《中国医院管理》 * |
王菊勇 等: ""我院新型药物临床试验电子信息化管理系统"", 《中国新药杂志》 * |
Cited By (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112655051A (en) * | 2018-05-14 | 2021-04-13 | 美国控股实验室公司 | Method and system for identifying subjects enrolled in a clinical trial |
CN108932968A (en) * | 2018-05-21 | 2018-12-04 | 上海市第六人民医院 | A kind of clinical trial subjects management system |
CN112154511A (en) * | 2018-05-23 | 2020-12-29 | 希米科医疗保健机构有限公司 | Subject candidate extraction method and subject candidate extraction system |
CN112154511B (en) * | 2018-05-23 | 2024-03-08 | 希米科医疗保健机构有限公司 | Subject candidate extraction method and subject candidate extraction system |
CN108830034A (en) * | 2018-05-25 | 2018-11-16 | 陈育聪 | A kind of medicine clinical development information processing system and its method |
CN109559236B (en) * | 2018-10-27 | 2023-08-08 | 深圳平安医疗健康科技服务有限公司 | Method and device for canceling information abnormality of medicines |
CN109559236A (en) * | 2018-10-27 | 2019-04-02 | 平安医疗健康管理股份有限公司 | The method and apparatus of drug reimbursement Information abnormity |
CN109671478A (en) * | 2018-12-24 | 2019-04-23 | 天津阿贝斯努科技有限公司 | Clinical test case report form quality control system and method for quality control |
CN109616190A (en) * | 2018-12-25 | 2019-04-12 | 天津阿贝斯努科技有限公司 | Center Ethic review management system and management method |
CN109817290A (en) * | 2018-12-25 | 2019-05-28 | 天津阿贝斯努科技有限公司 | One clinical trial phase management system and management method |
CN109978341A (en) * | 2019-02-28 | 2019-07-05 | 北京新研汇医药研发有限公司 | A kind of monitoring method and apparatus of clinical test |
CN110335649B (en) * | 2019-06-04 | 2024-01-16 | 林东方 | Clinical medicine test data platform based on Filemaker database |
CN110335649A (en) * | 2019-06-04 | 2019-10-15 | 林东方 | A kind of clinical drug trials data platform based on Filemaker database |
CN112712862A (en) * | 2019-10-24 | 2021-04-27 | 北京新研汇医药研发有限公司 | Method, device and system for generating clinical research time schedule |
CN111341455A (en) * | 2020-02-10 | 2020-06-26 | 厦门茶蕊生物医药科技有限公司 | Clinical test integrated cloud platform management system, method and storage medium |
CN111640475A (en) * | 2020-04-29 | 2020-09-08 | 上海米帝信息技术有限公司 | Management system for clinical test |
CN111599429A (en) * | 2020-05-19 | 2020-08-28 | 苏州筑奇医药科技有限公司 | Out-of-hospital data acquisition method, equipment device and storage medium for clinical testees |
CN111599429B (en) * | 2020-05-19 | 2023-11-03 | 中科筑奇医药科技(苏州)有限公司 | Clinical subject off-site data acquisition method, equipment device and storage medium |
CN111986743A (en) * | 2020-08-07 | 2020-11-24 | 上海神桥医药科技有限公司 | Medical auditing method and application thereof |
CN112185489A (en) * | 2020-10-14 | 2021-01-05 | 上海妙一生物科技有限公司 | Information reminding method, system, equipment and storage medium |
CN112164469A (en) * | 2020-10-14 | 2021-01-01 | 杭州卓健信息科技有限公司 | Clinical scientific research data acquisition management system |
CN112365940A (en) * | 2020-10-16 | 2021-02-12 | 零氪科技(北京)有限公司 | System and method for screening subjects |
CN113035295A (en) * | 2020-10-29 | 2021-06-25 | 上海米帝信息技术有限公司 | Patient information management system |
CN113053478A (en) * | 2021-03-11 | 2021-06-29 | 上海交通大学医学院附属新华医院 | Project and quality control system suitable for clinical test of medicine |
CN113139727B (en) * | 2021-04-23 | 2024-01-16 | 广东丸美生物技术股份有限公司 | Cosmetic human body efficacy test subject management system and method |
CN113139727A (en) * | 2021-04-23 | 2021-07-20 | 广东丸美生物技术股份有限公司 | Cosmetic human body efficacy test subject management system and method |
CN113327656A (en) * | 2021-06-09 | 2021-08-31 | 上海天蟾生物科技有限公司 | Clinical test detection recording method for arenobufagin hard mass softening and liver softening tablets |
CN113314192A (en) * | 2021-06-17 | 2021-08-27 | 医渡云(北京)技术有限公司 | Clinical trial data processing system, method, device and storage medium |
CN113707248A (en) * | 2021-08-31 | 2021-11-26 | 郑州大学第一附属医院 | Clinical trial subject examination and inspection process management system, method and computer storage medium |
CN113889205A (en) * | 2021-09-30 | 2022-01-04 | 上海柯林布瑞信息技术有限公司 | A screening method for clinical research patients and a corresponding device |
CN113889205B (en) * | 2021-09-30 | 2025-01-21 | 上海柯林布瑞信息技术有限公司 | A screening method for clinical research patients and corresponding device |
CN114360668A (en) * | 2021-12-24 | 2022-04-15 | 浙江太美医疗科技股份有限公司 | Data processing method, data processing device, data configuration device, computer equipment and storage medium |
CN114334044A (en) * | 2021-12-24 | 2022-04-12 | 浙江太美医疗科技股份有限公司 | Methods, apparatus, electronic devices and media for data presentation, project configuration |
CN114334072A (en) * | 2021-12-31 | 2022-04-12 | 科临达康医药生物科技(北京)有限公司 | Method, system and equipment for establishing clinical trial development plan database |
CN114388116A (en) * | 2022-01-14 | 2022-04-22 | 北京嘉和海森健康科技有限公司 | Processing method and system of visiting schedule table and electronic equipment |
CN116580798A (en) * | 2023-07-13 | 2023-08-11 | 南京纳实医学科技有限公司 | Research method for dynamic and accurate clinical test selection of subject medicine |
CN116580798B (en) * | 2023-07-13 | 2023-10-20 | 南京纳实医学科技有限公司 | Research method for dynamic and accurate clinical test selection of subject medicine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107480456A (en) | clinical trial management method and system | |
US11232377B2 (en) | Integrated clinical trial workflow system | |
Turki et al. | The regulatory technology “RegTech” and money laundering prevention in Islamic and conventional banking industry | |
US8595028B2 (en) | System and method for performing medical research across a vast patient population | |
US7711660B1 (en) | Processing health insurance data utilizing data quality rules | |
CN104956380A (en) | Method and apparatus for remote site monitoring | |
AU2014364002A1 (en) | Identification of candidates for clinical trials | |
Render et al. | Infrastructure for quality transformation: measurement and reporting in veterans administration intensive care units | |
Pennucci et al. | Piloting a web-based systematic collection and reporting of patient-reported outcome measures and patient-reported experience measures in chronic heart failure | |
Westerhof et al. | The impact of health information technology on hospital performance: a systematic integrative literature review | |
Myoa et al. | Leveraging real-world evidence in pharmacovigilance reporting | |
Gaines et al. | Mental Health Classification Outcomes Study | |
Li et al. | Laboratory Information Systems | |
Sluss | Reference laboratory utilization management | |
Fox et al. | Developing an expert panel process to refine health outcome definitions in observational data | |
Kittoe et al. | Exploring fraud and abuse in National Health Insurance Scheme (NHIS) using data mining technique as a statistical model | |
Troeung et al. | Optimizing the quality of Clinical Data in an Australian aged care and disability service to Improve Care Delivery and clinical outcomes: protocol for an agile lean six Sigma Study | |
Augusto et al. | Performance evaluation of health information systems using aris modeling and discrete-event simulation | |
Roukas et al. | Developing core economic parameter sets for asthma studies: a realist review and an analytical framework | |
Kritz et al. | Electronic medical record system at an opioid agonist treatment programme: study design, pre‐implementation results and post‐implementation trends | |
Ishak et al. | Exploring the suitability of a ward-based clinical pharmacy activity collection tool for ambulatory care practice: a mixed-methods study | |
Ishak et al. | Clinical Pharmacy Activity Collection Tool for Ambulatory Care Practice | |
Venkatraman et al. | Mapping the healthcare data landscape in Denmark | |
Bainathsah | The discovery, analysis and comparison of the patient discharge process-A case study. | |
Cornejo et al. | Design and Implementation of a Data Warehouse to Support Decision-Making in a Health Environment. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171215 |